Astrazeneca reported 10.51B in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
AstraZeneca AZN:LN 10.51B 1.79B
Astrazeneca AZN:US 10.51B 1.79B
Bristol Myers Squibb BMY:US $ 9.1B 247M
Canopy Growth Corp WEED:CN C$ 641.41M 350.48M
Catalent CTLT:US $ 1.06B 6M
Corcept Therapeutics CORT:US $ 62.16M 2.26M
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
Genmab GEN:DC 1.61B 205M
H. Lundbeck A/S LUN:DC 3.5B 550M
Horizon Pharma HZNP:US $ 690.93M 90.45M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Merk MRK:US $ 10332M 386M
Novartis NOVN:VX 9.96B 998M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Teva Pharmaceutical Industries TEVA:US 4.37B 352M
Valeant Pharmaceuticals VRX:CN C$ 1.63B 196M
Zoetis ZTS:US $ 1.26B 202M